BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22001236)

  • 1. Flanking nucleotide specificity for DNA mismatch repair-deficient frameshifts within activin receptor 2 (ACVR2).
    Chung H; Chaudhry J; Lai JF; Young DJ; Carethers JM
    Mutat Res; 2012 Jan; 729(1-2):73-80. PubMed ID: 22001236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flanking sequence specificity determines coding microsatellite heteroduplex and mutation rates with defective DNA mismatch repair (MMR).
    Chung H; Lopez CG; Young DJ; Lai JF; Holmstrom J; Ream-Robinson D; Cabrera BL; Carethers JM
    Oncogene; 2010 Apr; 29(15):2172-80. PubMed ID: 20140012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation rates of TGFBR2 and ACVR2 coding microsatellites in human cells with defective DNA mismatch repair.
    Chung H; Young DJ; Lopez CG; Le TA; Lee JK; Ream-Robinson D; Huang SC; Carethers JM
    PLoS One; 2008; 3(10):e3463. PubMed ID: 18941508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both microsatellite length and sequence context determine frameshift mutation rates in defective DNA mismatch repair.
    Chung H; Lopez CG; Holmstrom J; Young DJ; Lai JF; Ream-Robinson D; Carethers JM
    Hum Mol Genet; 2010 Jul; 19(13):2638-47. PubMed ID: 20418486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.
    Jung B; Doctolero RT; Tajima A; Nguyen AK; Keku T; Sandler RS; Carethers JM
    Gastroenterology; 2004 Mar; 126(3):654-9. PubMed ID: 14988818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.
    Campregher C; Honeder C; Chung H; Carethers JM; Gasche C
    Clin Cancer Res; 2010 Mar; 16(6):1950-6. PubMed ID: 20197483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
    Hempen PM; Zhang L; Bansal RK; Iacobuzio-Donahue CA; Murphy KM; Maitra A; Vogelstein B; Whitehead RH; Markowitz SD; Willson JK; Yeo CJ; Hruban RH; Kern SE
    Cancer Res; 2003 Mar; 63(5):994-9. PubMed ID: 12615714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetranucleotide Microsatellite Mutational Behavior Assessed in Real Time: Implications for Future Microsatellite Panels.
    Raeker MÖ; Pierre-Charles J; Carethers JM
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):689-704. PubMed ID: 31982570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
    Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.
    Jung BH; Beck SE; Cabral J; Chau E; Cabrera BL; Fiorino A; Smith EJ; Bocanegra M; Carethers JM
    Gastroenterology; 2007 Feb; 132(2):633-44. PubMed ID: 17258738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-infiltrating lymphocytes in colorectal cancers with microsatellite instability are correlated with the number and spectrum of frameshift mutations.
    Tougeron D; Fauquembergue E; Rouquette A; Le Pessot F; Sesboüé R; Laurent M; Berthet P; Mauillon J; Di Fiore F; Sabourin JC; Michel P; Tosi M; Frébourg T; Latouche JB
    Mod Pathol; 2009 Sep; 22(9):1186-95. PubMed ID: 19503063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGFBR2-dependent alterations of exosomal cargo and functions in DNA mismatch repair-deficient HCT116 colorectal cancer cells.
    Fricke F; Lee J; Michalak M; Warnken U; Hausser I; Suarez-Carmona M; Halama N; Schnölzer M; Kopitz J; Gebert J
    Cell Commun Signal; 2017 Apr; 15(1):14. PubMed ID: 28376875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines.
    Carethers JM; Pham TT
    In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms.
    Jung B; Gomez J; Chau E; Cabral J; Lee JK; Anselm A; Slowik P; Ream-Robinson D; Messer K; Sporn J; Shin SK; Boland CR; Goel A; Carethers JM
    PLoS One; 2009 Dec; 4(12):e8308. PubMed ID: 20011542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.
    Jung B; Smith EJ; Doctolero RT; Gervaz P; Alonso JC; Miyai K; Keku T; Sandler RS; Carethers JM
    Int J Cancer; 2006 May; 118(10):2509-13. PubMed ID: 16380996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compensation of loss of protein function in microsatellite-unstable colon cancer cells (HCT116): a gene-dependent effect on the cell surface glycan profile.
    Patsos G; André S; Roeckel N; Gromes R; Gebert J; Kopitz J; Gabius HJ
    Glycobiology; 2009 Jul; 19(7):726-34. PubMed ID: 19293232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens.
    Linnebacher M; Gebert J; Rudy W; Woerner S; Yuan YP; Bork P; von Knebel Doeberitz M
    Int J Cancer; 2001 Jul; 93(1):6-11. PubMed ID: 11391614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation.
    Scott S; Kimura T; Ichinohasama R; Bergen S; Magliocco A; Reimer C; Kerviche A; Sheridan D; DeCoteau JF
    Leuk Res; 2003 Jan; 27(1):23-34. PubMed ID: 12479849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational analysis of transforming growth factor beta receptor type II and DNA mismatch repair genes in sporadic endometrial carcinomas with microsatellite instability.
    Ohwada M; Suzuki M; Saga Y; Suzuki T; Ikeda M; Yamada M; Sato I
    Oncol Rep; 2000; 7(4):789-92. PubMed ID: 10854545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncating mutations in the ACVR2 gene attenuates activin signaling in prostate cancer cells.
    Rossi MR; Ionov Y; Bakin AV; Cowell JK
    Cancer Genet Cytogenet; 2005 Dec; 163(2):123-9. PubMed ID: 16337854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.